In summary, ALO may reduce HI insult‐induced apoptosis and cerebral infarction by inhibiting glial cell activation and neuroinflammation mediated by the TLR4/MyD88/NF‐κB signaling pathway, thereby improving long‐term neurological function. The gene discussed is NFKB1; the disease is cerebral infarction.